glp-1 pharmacology and Anesthesia: Considerations and Cautions for CRNAs How GLP-1 Receptor Agonists Evolved

[DOI] [PubMed] [Google Scholar] [63].Knudsen LB, Nielsen PF, Huusfeldt PO, Johansen NL, Madsen K, Pedersen FZ, Thogersen H, Wilken M, Agerso H, Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration, Journal of medicinal chemistry, 43 (2000) 16641669

Knowing whether your plan requires a diagnosis of type 2 diabetes versus a diagnosis of obesity can help you and your doctor choose the right medication to pursue, along with deciding whether you should use GLP-1 and insulin together as part of your treatment plan

That means not limiting GLP-1 coverage to six months or a year, as many insurers do, and providing the same support that made GLP-1s so effective in clinical testing

The recommendations suggest that the use of GLP-1 RAs is projected to be of high value in comparison to other classes of diabetes medications